AWAgnieszka Wilkos-Kuc

Agnieszka Wilkos-Kuc

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Agnieszka Wilkos-Kuc has a total of 8 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Neovascular glaucoma

    by Olga Majkowska, Agnieszka Wilkos-Kuc, Piotr Witold Stępień, Tomasz Żarnowski, Ewa Kosior-Jarecka

    Neovascular glaucoma is an aggressive form of secondary angle-closure glaucoma that can potentially lead to blindness. It is characterized by neovascularization of the iris and the drainage angle. The proliferation of fibrovascular tissue within the drainage angle leads to the formation of peripheral anterior synechiae and an increase in intraocular pressure. Neovascular glaucoma develops as a consequence of ischemia and hypoxia in the posterior segment of the eye. The ischemic retina produces pro-angiogenic factors. The most important factor in the process of neovascularization is vascular endothelial growth factor. The most common underlying causes of neovascular glaucoma are diabetic retinopathy, central retinal vein occlusion, and ocular ischemic syndrome. The course of neovascular glaucoma can be divided into four stages: pre-rubeosis stage, iris rubeosis, secondary open-angle glaucoma, and secondary angle-closure glaucoma. Management of neovascular glaucoma focuses on treating retinal ischemia, controlling neovascularization, and reducing intraocular pressure. The aim of treatment is to prevent vision loss through panretinal photocoagulation, intravitreal and intracameral anti-VEGF injections, and glaucoma treatment, including pharmacological therapy and surgical procedures. It is essential to address the underlying disease.

  • Open Access

    Predictive Value of Bleb Vascularity after Mitomycin C Augmented Trabeculectomy

    by Aleksandra Wlaź, Anna Kuna, Agnieszka Wilkos-Kuc, Agnieszka Rozegnał-Madej, Tin Aung, Tomasz Żarnowski

    Background: To evaluate the relationship between bleb vascularity and surgical outcome one year after mitomycin C (MMC) augmented trabeculectomy. Methods: This was a prospective study of 51 eyes of 44 patients after MMC-augmented primary trabeculectomy with follow-up of 12 months. The total vessel area of a bleb was measured with ImageJ software on color photographs of the bleb on day 1 and 14, then months 1, 3, 6 and 12 after trabeculectomy. Blebs were classified clinically as successful (intraocular pressure (IOP) ≤ 18 mmHg and a >30% reduction in IOP without antiglaucoma medications or additional surgical interventions) or failed. Linear regression analysis was performed to determine the correlation of bleb vascularity with IOP and outcome. Results: At 1 year, 40 eyes (78.4%) were classified as successful and 11 eyes (21.6%) as failed. The mean bleb vascularity at 1, 3 and 12 months after surgery was significantly higher in failed blebs (16.31% vs. 13.01%, p = 0.005, 14.93% vs. 10.15%, p = 0.001, 8.99% vs. 6.37%, p = 0.011, respectively). There were no significant differences in mean bleb vascularity at 1 and 14 days postoperatively in successful and failed blebs. The results revealed a significant association between vessel area at 1 and 3 months after trabeculectomy with IOP at 6 months postoperatively (p = 0.005 and p = 0.009, respectively). Conclusions: In this prospective study, we demonstrated a strong relationship between bleb vascularity and the surgical outcomes of trabeculectomy. Vascularity of the filtering bleb during early postoperative period was not correlated with IOP or success of trabeculectomy at one year. Increased bleb vascularity 1, 3 and 12 months after trabeculectomy appears to predict surgical failure at 1 year after trabeculectomy.